Learn / Epidemiology / Study designs
Cohort studies
14 minute read · 6-question quiz
What you will learn
Describe prospective, retrospective and ambispective cohort designs
Calculate relative risk, rate ratio and attributable risk from cohort data
Identify the main threats: loss to follow-up, misclassification and confounding
In a cohort study, you start with exposure: you follow groups of exposed and unexposed people over time to see who develops the outcome. It follows the natural direction of cause and effect.
Types
- Prospective: the cohort is assembled now; follow-up occurs in the future. Best data quality, expensive and slow. (Framingham Heart Study, Rakai Community Cohort Study.)
- Retrospective (historical): exposure and outcome have already happened; the researcher uses past records (occupational records linked to cancer registry). Fast, relies on record quality.
- Ambispective: a mix.
Strengths
- Clear temporality: exposure precedes outcome.
- Direct measures of incidence and risk in both groups.
- Can study many outcomes from one exposure; good for rare exposures (a cohort of workers exposed to a chemical).
- Less recall bias than case-control studies.
Weaknesses
- Expensive and slow, especially for rare or long-latency diseases.
- Loss to follow-up can bias results if those lost differ.
- Exposure may change over time (smoking cessation); need updated measures.
- Confounding is still present (not randomised).
Measures from a cohort
| Measure | Formula | Question answered |
| Risk ratio (RR) | Risk exposed ÷ risk unexposed | How many times as likely? |
| Rate ratio | Rate exposed ÷ rate unexposed | Same, using person-time |
| Risk difference | Risk exposed − risk unexposed | How many extra cases? |
| Attributable fraction (exposed) | (RR − 1) ÷ RR | What share of disease in the exposed is due to exposure? |
| Population attributable fraction | p(RR − 1) ÷ [1 + p(RR − 1)] | What share of disease in the whole population is due to exposure? |
(Here p is the proportion of the population exposed.)
Dealing with loss to follow-up
Retention is the cohort's lifeblood. Collect multiple contact details, tracking visits, regular communication, incentives within ethical limits. Compare those lost with those retained; use inverse probability weights or sensitivity analyses to see whether losses could change the result. Aim for 80% or more follow-up, and treat below 60% as seriously threatening.
Famous cohorts
Framingham (cardiovascular risk), Nurses' Health Study, British Doctors Study (smoking and lung cancer), Rakai Community Cohort (HIV), Birth to Twenty (South Africa), Mbarara Adolescent Cohorts. Large cohorts increasingly use biobanks and linked electronic records.
Summary
A cohort follows exposed and unexposed groups forward to compare incidence.
It establishes temporality and gives RR, rate ratio, risk difference and attributable fractions.
It suits rare exposures and multiple outcomes but is slow, costly and vulnerable to losses.
PAF = p(RR − 1) / [1 + p(RR − 1)] gives the public-health impact.
Retention and exposure updating are central to quality.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.